$萊斯康製藥(LXRX.US)$Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 17.65 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $1.130 million which missed the analyst consensus estimate of $1.401 million by 19.33 percent. This is a 4.61K percent increase over sales of $24.000 thousand the same period last...
71685348 : 2.019